Bosutinib: a review of its use in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
about
Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase InhibitorsClinical advances in the management of chronic myelogenous leukemia: focus on bosutinib and patient considerationsNovel targeted therapies for eosinophil-associated diseases and allergyBcr-Abl tyrosine kinase inhibitors: a patent review.An overview of quinoline as a privileged scaffold in cancer drug discovery.Synergism between bosutinib (SKI-606) and the Chk1 inhibitor (PF-00477736) in highly imatinib-resistant BCR/ABL⁺ leukemia cells.
P2860
Bosutinib: a review of its use in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bosutinib: a review of its use ...... chronic myelogenous leukemia.
@en
type
label
Bosutinib: a review of its use ...... chronic myelogenous leukemia.
@en
prefLabel
Bosutinib: a review of its use ...... chronic myelogenous leukemia.
@en
P2860
P1433
P1476
Bosutinib: a review of its use ...... chronic myelogenous leukemia.
@en
P2093
Paul L McCormack
Yahiya Y Syed
P2860
P2888
P304
P356
10.1007/S40259-013-0082-X
P577
2014-02-01T00:00:00Z